| __timestamp | Rhythm Pharmaceuticals, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 5280000 | 15411924 |
| Thursday, January 1, 2015 | 7148000 | 22593274 |
| Friday, January 1, 2016 | 19594000 | 33173050 |
| Sunday, January 1, 2017 | 22894000 | 62224159 |
| Monday, January 1, 2018 | 50337000 | 95607434 |
| Tuesday, January 1, 2019 | 109450000 | 221269028 |
| Wednesday, January 1, 2020 | 90450000 | 400745069 |
| Friday, January 1, 2021 | 104128000 | 580520000 |
| Saturday, January 1, 2022 | 108630000 | 663366000 |
| Sunday, January 1, 2023 | 134951000 | 755113687 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, argenx SE and Rhythm Pharmaceuticals, Inc. have been at the forefront of this race. Since 2014, argenx SE has consistently outpaced Rhythm Pharmaceuticals in R&D investment, with a staggering 390% increase by 2023. In contrast, Rhythm Pharmaceuticals has shown a robust growth of 2,455% in the same period, reflecting its aggressive push towards groundbreaking therapies. By 2023, argenx SE's R&D expenses reached nearly 7.6 times that of Rhythm Pharmaceuticals, highlighting its dominant position. This financial commitment underscores the strategic focus of both companies on pioneering treatments that could redefine patient care. As these two giants continue to invest heavily in R&D, the biotech industry eagerly anticipates the next wave of innovations.
Analyzing R&D Budgets: argenx SE vs BeiGene, Ltd.
R&D Insights: How argenx SE and United Therapeutics Corporation Allocate Funds
Research and Development: Comparing Key Metrics for argenx SE and Insmed Incorporated
Research and Development Expenses Breakdown: argenx SE vs Viatris Inc.
Research and Development Investment: argenx SE vs Blueprint Medicines Corporation
Research and Development Expenses Breakdown: argenx SE vs Grifols, S.A.
Research and Development Expenses Breakdown: argenx SE vs Ligand Pharmaceuticals Incorporated
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Incyte Corporation vs Rhythm Pharmaceuticals, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Rhythm Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Rhythm Pharmaceuticals, Inc.
Comparing Innovation Spending: Axsome Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.